{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:14:35Z","timestamp":1782504875778,"version":"3.54.5"},"reference-count":36,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821520"],"award-info":[{"award-number":["821520"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and compare algorithms for identifying gestational diabetes mellitus (GDM) across European electronic healthcare databases and evaluate their impact on the estimated prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multi-national cohort study using routinely collected electronic healthcare data<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>National and regional databases in five European countries (Norway, Finland, Italy, Spain and France), in primary and\/or secondary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Pregnancy cohorts resulting in stillbirths or live births between 2009 and 2020, comprising 602 897 pregnancies in Norway, 507 904 in Finland, 374 009 in Italy, 193 495 in Spain and 116 762 in France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcomes<\/jats:title>\n                    <jats:p>\n                      The primary outcome was the prevalence of GDM identified using six algorithms: (1) Only diagnosis; (2) Diagnosis or prescription; (3) Two diagnoses or prescriptions (\n                      <jats:italic>2DxRx<\/jats:italic>\n                      ); (4) Diagnosis including unspecified diabetes in pregnancy or prescription (\n                      <jats:italic>DxRx broad<\/jats:italic>\n                      ); (5) Diagnosis excluding pre-existing diabetes in pregnancy or prescription; (6) Registration of GDM in a birth registry (\n                      <jats:italic>BR<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The strictest algorithm (\n                      <jats:italic>2DxRx<\/jats:italic>\n                      ) resulted in the lowest GDM prevalence, while the broadest (\n                      <jats:italic>DxRx broad<\/jats:italic>\n                      ) resulted in the highest, except in France where it was\n                      <jats:italic>BR<\/jats:italic>\n                      . In the Nordic countries, GDM prevalence varied only slightly by algorithm; greater variations were observed in other countries. The prevalence ranged from 3.5% (95% CI: 3.5% to 3.5%) to 4.6% (95% CI: 4.5% to 4.7%) in Norway; 12.1% (95% CI: 12.0% to 12.2%) to 15.8% (95% CI: 15.7% to 15.9%) in Finland, where prevalence was much higher than elsewhere. The prevalence ranged from 1.3% (95% CI: 1.3% to 1.3%) to 5.4% (95% CI: 5.3% to 5.5%) in Italy; 1.6% (95% CI: 1.5% to 1.7%) to 6.2% (95% CI: 6.1% to 6.3%) in Spain; and 1.7% (95% CI: 1.6% to 1.8%) to 5.8% (95% CI: 5.7% to 5.9%) in France.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this multinational study, GDM prevalence ranged from 1.3% to 15.8% depending on the algorithm and database. Nordic countries showed smaller differences in prevalence between algorithms, while the other countries showed larger variations, likely due to differences in coding practices, healthcare systems and database coverage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-102343","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T01:40:47Z","timestamp":1759714847000},"page":"e102343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-4289","authenticated-orcid":false,"given":"Ditte","family":"M\u00f8lgaard-Nielsen","sequence":"first","affiliation":[{"name":"Novo Nordisk A\/S, Bagsv\u00e6rd, Capital Region of Denmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1483-5020","authenticated-orcid":false,"given":"Vera","family":"Mitter","sequence":"additional","affiliation":[{"name":"University of Oslo, Oslo, Norway"},{"name":"Bern University of Applied Sciences, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8787-3183","authenticated-orcid":false,"given":"Angela","family":"Lupattelli","sequence":"additional","affiliation":[{"name":"University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vjola","family":"Hoxhaj","sequence":"additional","affiliation":[{"name":"Utrecht University, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7745-2887","authenticated-orcid":false,"given":"Constanza L","family":"Andaur Navarro","sequence":"additional","affiliation":[{"name":"Utrecht University, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hayati","sequence":"additional","affiliation":[{"name":"University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lopez-Leon","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, Portland, Oregon, USA"},{"name":"Rutgers University New Brunswick, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-612X","authenticated-orcid":false,"given":"Joan K","family":"Morris","sequence":"additional","affiliation":[{"name":"University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Geldof","sequence":"additional","affiliation":[{"name":"Janssen Biologics BV, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-2987","authenticated-orcid":false,"given":"Susan","family":"Jordan","sequence":"additional","affiliation":[{"name":"Swansea University, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-4749","authenticated-orcid":false,"given":"Maarit K","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Finnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visa","family":"Martikainen","sequence":"additional","affiliation":[{"name":"Finnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Manfrini","sequence":"additional","affiliation":[{"name":"University of Ferrara, Ferrara, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cammarota","sequence":"additional","affiliation":[{"name":"University of Ferrara, Ferrara, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Neville","sequence":"additional","affiliation":[{"name":"University Hospital of Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-265X","authenticated-orcid":false,"given":"Laia","family":"Barrachina-Bonet","sequence":"additional","affiliation":[{"name":"Foundation for the Promotion of Health and Bio-medical Research in the Valencian Region, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Cavero-Carbonell","sequence":"additional","affiliation":[{"name":"Foundation for the Promotion of Health and Bio-medical Research in the Valencian Region, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garc\u00eda-Villodre","sequence":"additional","affiliation":[{"name":"Foundation for the Promotion of Health and Bio-medical Research in the Valencian Region, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Caillet","sequence":"additional","affiliation":[{"name":"Toulouse University, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beslay","sequence":"additional","affiliation":[{"name":"Toulouse University, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[{"name":"Toulouse University, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4853-4434","authenticated-orcid":false,"given":"Marleen M H J","family":"van Gelder","sequence":"additional","affiliation":[{"name":"University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[{"name":"University of Oslo, Oslo, Norway"},{"name":"National Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"2025120415054421000_15.10.e102343.1","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.2337\/dc07-s206","article-title":"Increasing prevalence of gestational diabetes mellitus: a public health perspective","volume":"30 Suppl 2","author":"Ferrara","year":"2007","journal-title":"Diabetes Care"},{"key":"2025120415054421000_15.10.e102343.2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.10.1862"},{"key":"2025120415054421000_15.10.e102343.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2008.09.002"},{"key":"2025120415054421000_15.10.e102343.4","doi-asserted-by":"crossref","unstructured":"Paulo MS , Abdo NM , Bettencourt-Silva R , et al . Gestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies. Front Endocrinol 2021;12. doi:10.3389\/fendo.2021.691033","DOI":"10.3389\/fendo.2021.691033"},{"key":"2025120415054421000_15.10.e102343.5","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(09)60515-8","article-title":"Gestational diabetes: the need for a common ground","volume":"373","author":"Reece","year":"2009","journal-title":"The Lancet"},{"key":"2025120415054421000_15.10.e102343.6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2017.03.030","article-title":"Prevalence of gestational diabetes mellitus in Europe: A meta-analysis","volume":"129","author":"Eades","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2025120415054421000_15.10.e102343.7","unstructured":"WHO . Definition, diagnosis and classification of diabetes mellitus and its complications. 1999. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/66040\/WHO_NCD_NCS_99.2.pdf?sequence=1&isAllowed=y"},{"key":"2025120415054421000_15.10.e102343.8","unstructured":"WHO . Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/85975\/WHO_NMH_MND_13.2_eng.pdf?sequence=1"},{"key":"2025120415054421000_15.10.e102343.9","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S002"},{"key":"2025120415054421000_15.10.e102343.10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s13300-020-00865-3","article-title":"American Diabetes Association \u201cStandards of Medical Care-2020 for Gestational Diabetes Mellitus\u201d: A Critical Appraisal","volume":"11","author":"Goyal","year":"2020","journal-title":"Diabetes Ther"},{"key":"2025120415054421000_15.10.e102343.11","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1016\/j.vaccine.2017.01.043","article-title":"Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"35","author":"Kachikis","year":"2017","journal-title":"Vaccine (Auckl)"},{"key":"2025120415054421000_15.10.e102343.12","first-page":"557","article-title":"Maternal age and screening for gestational diabetes: a population-based study","volume":"73","author":"Coustan","year":"1989","journal-title":"Obstet Gynecol"},{"key":"2025120415054421000_15.10.e102343.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160648","article-title":"Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project","volume":"11","author":"Roberto","year":"2016","journal-title":"PLoS One"},{"key":"2025120415054421000_15.10.e102343.14","first-page":"1189","article-title":"Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies","volume":"4","author":"Gini","year":"2016","journal-title":"EGEMS (Wash DC)"},{"key":"2025120415054421000_15.10.e102343.15","doi-asserted-by":"crossref","first-page":"B56","DOI":"10.1016\/j.vaccine.2019.07.045","article-title":"Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project","volume":"38","author":"Gini","year":"2020","journal-title":"Vaccine (Auckl)"},{"key":"2025120415054421000_15.10.e102343.16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cpt.2476","article-title":"From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding","volume":"111","author":"Thurin","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"2025120415054421000_15.10.e102343.17","unstructured":"Gini R . Report with publications on results of component algorithms (D7.16). Zenodo; 2024. Available: https:\/\/zenodo.org\/records\/13860418"},{"key":"2025120415054421000_15.10.e102343.18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/pds.2217","article-title":"Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy","volume":"20","author":"Andrade","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025120415054421000_15.10.e102343.19","doi-asserted-by":"crossref","first-page":"100814","DOI":"10.1016\/j.ajogmf.2022.100814","article-title":"Assessment of the Validity of Administrative Data for Gestational Diabetes Ascertainment","volume":"5","author":"Hsu","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2025120415054421000_15.10.e102343.20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/EDE.0000000000001311","article-title":"Validation of ICD-10 Codes for Gestational and Pregestational Diabetes During Pregnancy in a Large, Public Hospital","volume":"32","author":"Stanhope","year":"2021","journal-title":"Epidemiology"},{"key":"2025120415054421000_15.10.e102343.21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/dme.13030","article-title":"Validation of administrative data case definitions for gestational diabetes mellitus","volume":"34","author":"Bowker","year":"2017","journal-title":"Diabet Med"},{"key":"2025120415054421000_15.10.e102343.22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/dme.13271","article-title":"Validation of administrative and clinical case definitions for gestational diabetes mellitus against laboratory results","volume":"34","author":"Bowker","year":"2017","journal-title":"Diabet Med"},{"key":"2025120415054421000_15.10.e102343.23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jcjd.2023.07.003","article-title":"Validity of Alternative Claims-based Algorithms for Type 1, Type 2, and Gestational Diabetes in Pregnancy","volume":"47","author":"Ngwezi","year":"2023","journal-title":"Can J Diabetes"},{"key":"2025120415054421000_15.10.e102343.24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcjd.2022.06.010","article-title":"Validation of Algorithms to Identify Gestational Diabetes From Population-level Health-care Administrative Data","volume":"47","author":"Shah","year":"2023","journal-title":"Can J Diabetes"},{"key":"2025120415054421000_15.10.e102343.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035218","article-title":"Validation study: evaluation of the metrological quality of French hospital data for perinatal algorithms","volume":"10","author":"Goueslard","year":"2020","journal-title":"BMJ Open"},{"key":"2025120415054421000_15.10.e102343.26","unstructured":"Hoxhaj V , Alsina E , Anduur Navarro C . UMC-Utrecht-RWE\/ConcePTION-DP4_Migraine: V5.0. Zenodo; 2024. Available: https:\/\/zenodo.org\/records\/14412550"},{"key":"2025120415054421000_15.10.e102343.27","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-S016"},{"key":"2025120415054421000_15.10.e102343.28","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0102"},{"key":"2025120415054421000_15.10.e102343.29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/aogs.13074","article-title":"New guidelines for screening, diagnosing, and treating gestational diabetes - evaluation of maternal and neonatal outcomes in Finland from 2006 to 2012","volume":"96","author":"Ellenberg","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025120415054421000_15.10.e102343.30","unstructured":"Svangerskapsdiabetes - nasjonal faglig retningslinje [gestational diabetes - national guidelines]. 2023. Available: https:\/\/www.helsedirektoratet.no\/retningslinjer\/svangerskapsdiabetes"},{"key":"2025120415054421000_15.10.e102343.31","doi-asserted-by":"crossref","unstructured":"Eskild A , Klovning A , Swensen E , et al . [Glucose tolerance testing of most pregnant women is a poor idea]. tidsskrift for den norske laegeforening. 2019. Available: https:\/\/tidsskriftet.no\/2019\/01\/debatt\/glukosebelastningstesting-av-de-fleste-gravide-er-en-darlig-ide","DOI":"10.4045\/tidsskr.18.0898"},{"key":"2025120415054421000_15.10.e102343.32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.diabres.2017.08.003","article-title":"Screening for gestational diabetes in Tuscany, Italy. A population study","volume":"132","author":"Di Cianni","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2025120415054421000_15.10.e102343.33","unstructured":"Beucher G , Burguet A , Cosson E , et al . Recommandations pour la pratique clinique le diab\u00e8te gestationnel. Paris; 2010. Available: https:\/\/cngof.fr\/app\/uploads\/2023\/06\/RPC_DIABETE_2010.pdf?x68656"},{"key":"2025120415054421000_15.10.e102343.34","unstructured":"Bafcops M , Bailly M , Bouvattier C , et al . RECOMMANDATIONS pour la PRATIQUE CLINIQUE. 1996. Available: http:\/\/www.cngof.asso.fr\/data\/RCP\/diabete_1996.pdf"},{"key":"2025120415054421000_15.10.e102343.35","doi-asserted-by":"crossref","unstructured":"Stene LC , Eidem I , Vangen S , et al . The validity of the diabetes mellitus diagnosis in the Medical Birth Registry of Norway. Nor J Epidemiol 2007;17. doi:10.5324\/nje.v17i2.158","DOI":"10.5324\/nje.v17i2.158"},{"key":"2025120415054421000_15.10.e102343.36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/aogs.14999","article-title":"Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test","volume":"104","author":"Etel\u00e4inen","year":"2025","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-102343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:07:20Z","timestamp":1764889640000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-102343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,5]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/bmjopen-2025-102343"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-102343","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}